Webborn P J H, Parker A J, Denton R L, Riley R J
Physical and Metabolic Science, AstraZeneca R&D Charnwood, Loughborough, UK.
Xenobiotica. 2007 Oct-Nov;37(10-11):1090-109. doi: 10.3109/00498250701557266.
The importance of hepatic uptake transporters in drug clearance is well recognized. The subject is reviewed with the intention of providing an overview of the concepts in order to link the increasing knowledge of transporter-mediated uptake into established models of hepatic clearance. In order to understand and quantify their impact, models of hepatic elimination that incorporate permeability barriers are required. Models that include both active and passive uptake into hepatocytes are discussed and simulations of the influence of active uptake and passive diffusion on hepatic clearance are presented. The advantages and weaknesses of a number of in vitro assays of hepatic uptake are described, and their ability to predict hepatic clearance is reviewed.
肝脏摄取转运体在药物清除中的重要性已得到充分认识。本文对该主题进行综述,旨在概述相关概念,以便将关于转运体介导摄取的日益增多的知识与已有的肝脏清除模型联系起来。为了理解和量化它们的影响,需要包含通透性屏障的肝脏消除模型。讨论了包括肝细胞主动和被动摄取的模型,并给出了主动摄取和被动扩散对肝脏清除影响的模拟结果。描述了多种肝脏摄取体外测定方法的优缺点,并对其预测肝脏清除的能力进行了综述。